These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 776508)

  • 21. [Treatment of gastroduodenal ulcers through the combination calcium acexamate-light bismuth nitrate].
    Hureau J; Bourdais JP
    Med Chir Dig; 1973; 2(4):xxxi-xxxiv. PubMed ID: 4612265
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preliminary results of treatment of chronic aggressive hepatitis with d-penicillamine (Cuprenil Polfa)].
    Eisner M; Goertz J; Dobrohorska H; Bohdanowicz I
    Pol Tyg Lek; 1973 Oct; 28(44):1721-4. PubMed ID: 4764108
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic results of the use of Leukeran as an immunosuppressive agent in chronic hepatitis].
    Phlippen R; Schumacher K; Gross R; Eder M
    Tijdschr Gastroenterol; 1970; 13(2):114-28. PubMed ID: 4921502
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-term treatment of chronic aggressive hepatitis and liver cirrhosis using immunosuppressive agents].
    Bannaski H
    Med Welt; 1974 Sep; 25(39):1551-5. PubMed ID: 4427553
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current approaches to using beta-carotenoids in chronic hepatitis in flight personnel].
    Preobrazhenskiĭ VN; Vasilenko VV
    Aviakosm Ekolog Med; 1996; 30(3):45-6. PubMed ID: 8963295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Favorable effect of chloroquine on chronic refractory subaggressive hepatitis].
    Bataller Sifré R; Ortolano Gómez A; Tebar Massó J; Berto Navarro R
    Rev Esp Enferm Apar Dig; 1975 Feb; 45(2):123-8. PubMed ID: 1121602
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of chronic hepatitis (author's transl)].
    Bode JC; Vido I; Schmidt FW
    Leber Magen Darm; 1977 Oct; 7(5):310-6. PubMed ID: 926981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Open clinical experience with uridine-diphosphoglucose in icteric hepatopathies of acute and chronic course].
    Güemes Díaz F; Conesa Picó OR; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1973 May; 40(3):327-34. PubMed ID: 4792335
    [No Abstract]   [Full Text] [Related]  

  • 29. Medical treatment of chronic hepatitis. Results of a retrospective study.
    Thaler H
    Tokai J Exp Clin Med; 1980 Jul; 5(3):361-6. PubMed ID: 7222126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multicenter clinical evaluation of immunosuppressive therapy in chronic aggressive hepatitis].
    Pol Tyg Lek; 1975 Jun; 30(26):1093-6. PubMed ID: 1135090
    [No Abstract]   [Full Text] [Related]  

  • 31. Levamisole therapy in chronic hepatitis--results of a multicentric double blind trial.
    Nilius R; Schentke U; Otto L; Teichmann W; Zipprich B; Schmidt W; Brügmann E; Busse HJ
    Hepatogastroenterology; 1983 Jun; 30(3):90-2. PubMed ID: 6350136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic activity of 2,4-dihydroxy-6-pyrimidine carbonate of 4-amino-5-carbamide-imidazole].
    Pasotti C
    Clin Ter; 1975 Nov; 75(3):281-9. PubMed ID: 776509
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in some blood chemical parameters in patients with chronic liver diseases treated with calcium-2,2'-disulfohexanoate].
    Turpini R; Scotti A; Brusoni V; Perego M
    Clin Ter; 1980 Jun; 93(6):689-94. PubMed ID: 7428323
    [No Abstract]   [Full Text] [Related]  

  • 34. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of acute and chronic liver diseases with calcium-2,2'-disulfohexanoate].
    Ravetta A
    Clin Ter; 1979 Aug; 90(4):357-68. PubMed ID: 262631
    [No Abstract]   [Full Text] [Related]  

  • 36. [Further experience with azathioprine therapy in chronic aggressive hepatitis: clinical results].
    Mancinella A; Palermo M; Guglielmi G
    Clin Ter; 1972 May; 61(4):349-59. PubMed ID: 5050949
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of chronic active hepatitis (CAH): a retrospective review of 130 patients.
    Giusti G; Ruggiero G; Galanti B; Piccinino F; Russo M; Galante D; Sagnelli E; Utili R; Pasquale G; Nardiello S; Aloisio V
    Hepatogastroenterology; 1981 Oct; 28(5):245-9. PubMed ID: 7047337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of two double-blind studies on the effect of silymarine in chronic hepatitis (author's transl)].
    Kiesewetter E; Leodolter I; Thaler H
    Leber Magen Darm; 1977 Oct; 7(5):318-23. PubMed ID: 926982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.